Purpose: There are few studies that have focused on the predictors of recurrence after gastrectomy for gastric carcinoma. This study analyzed the patients who died of recurrent gastric carcinoma and we attempted to clarify the clinicopathologic factors that are associated with the timing of recurrence. Materials and Methods: From June 1992 to March 2009, 1,795 patients underwent curative gastric resection at the Department of Surgery, Hanyang University College of Medicine. Among them, 428 patients died and 311 of these patients who died of recurrent gastric carcinoma were enrolled in this study. The clinicopathologic findings were compared between the 72 patients who died within one year after curative gastrectomy (the early recurrence group) and the 92 patients who died 3 years after curative gastrectomy (the late recurrence group). Results: Compared with the late recurrence group, the early recurrence group showed an older age, a more advanced stage, a poorly differentiated type of cancer and a significantly higher tendency to have lymphatic invasion, vascular invasion and perineural invasion.Especially in the gastric cancer patients with a more advanced stage (stage III and IV), the early recurrence group was characterized by a significantly higher preoperative serum carcino embryonic antigen level, perineural invasion and a relatively small number of dissected lymph nodes. Conclusions: The clinicopathologic characteristics of recurrent gastric cancer are significantly different according to the stage of disease, and even in the same stage. For the early detection of recurrence after curative surgery, it is important to recognize the clinicopathological factors that foretell a high risk of recurrence. It is mandatory to make an individualized surveillance schedule according to the clinicopathologic factors.
Introduction
The incidence of gastric cancer has recently been gradually decreasing, and particularly the proportion of cases of early gastric cancer among all the cases of gastric cancer is rapidly on the rise. Yet the mortality rate due to gastric cancer is still high.
(1,2) Surgical resection is currently the only radical treatment for gastric cancer, and the 5-year survival rate is continuously on the increase because of performing radical resection, extended lymphadenectomy, postsurgical chemotherapy and adjuvant immunotherapy. Nevertheless, death is due to recurrence in 60~70% of the cases of gastric cancer.(3) In some cases, it can be resected again, which allows long term survival. Yet gastric cancer recurs as diverse patterns in several organs, and it is difficult to distinguish the recurrence patterns. Hence, this is treated by conservative treatments, and prognosis is poor.(4-6) The level of tumor infiltration and the presence or absence of lymph node metastasis are currently the important prognostic factors, but there are insufficient studies on the risk factors pertinent to the time of recurrence or the recurrence patterns. To understand the factors associated with recurrence and to help appropriately treat the at-risk group after surgery, we analyzed the clinicopathological Abdominal wall 2
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Results

The interval from surgery to recurrence
The interval of the 311 patients who died of recurred gastric cancer after radical treatment was from a minimum of 2 months to a maximum of 147 months, the average follow-up period was 30 months and the mean age was 56.2 years. Among them, the number of patients who recurred within 1 year was 72 patients, which was 23.2% of all the patients. The number of patients who recurred after 3 years was 92 patients, and they accounted for 29.6% of all the patients (Fig. 1) . The cumulative recurrence rate up to 2 years after surgery was 39.2%, and the recurrence rate at the third year was 79.4% (Fig. 2 ).
The recurrence pattern
In regard to the recurrence pattern of all 311 patients, there
were 170 patients with peritoneal recurrence, which was the most prevalent, 57 patients with hematogenous recurrence and 29 patients with local recurrence. There were 55 patients whose recurrence area Fig. 2 . Cummulativee rate of recurrence aft er curative resection. 
Clinicopathological characteristics according to the recurrence time
The clinicocharacteristics of the early recurrence group and the late recurrence group were compared. Regarding the age distribution, the age of the early recurrence group was higher (P=0.025). Regarding the distribution according to the 6th AJCC staging system an advanced disease stage was more prevalent in the early recurrence group than in the late recurrence group (P＜0.001).
In addition, the cases with lymph node infiltration, vascular infiltration or perineural infiltration were significantly more prevalent in the early recurrence group than in the late recurrence group (P=0.029, P=0.044, P=0.001). Concerning the grade of histological differentiation, the cases with poorly differentiated histological types were significantly more abundant in the early recurrence group than in the late recurrence group (P=0.019) ( Table   2 ).
Other than that, age, the surgical methods, additional adjuvant therapy, the range of lymphadenectomy, the number of resected lymph nodes and the presurgical serum CEA and CA19-9 values of the two groups were not significantly different.
Multivariate analysis was performed using logistic regression on age, the 6th AJCC staging system lymph node infiltration, vascular infiltration and perineural infiltration, which were all significant on the univariate analysis. It was observed that for the early recurrence cases, the stastically significant factors were an advanced stage (stage III), perineural infiltration and age (Table 3 ).
Clinicopathological characteristics of the stage III and IV patients according to the recurrence time
Among the patients, for the stage III and stage IV patients whose incidence of recurrence was particularly high, we compared the clinicopathological characteristic according to the recurrence time for the patients with the same disease stage. In regard to the Table 4) .
Multivariate analysis was performed by applying Logistic regression on the number of resected lymph nodes as well as perineural infiltration, which were significant on univariate analysis.
It was observed that only perinerual infiltration was significantly more prevalent in the early recurrence group (P=0.006) ( Table 5 ).
Discussion
The incidence and mortality rate of gastric cancer are on the decrease, and due to the development of diagnostic methods, the rate of discovering early gastric cancer as well as the 5-year In most studies, recurrence has been classified as the early recurrence group and the late recurrence group based on 2 years and 3 years, respectively, and the risk factors associated with recurrence or the survival period after recurrence were analyzed. In addition, Yokota et al. (14) classified 251 patients who died of recurrence after radical stomach resection as the group that recurred within 2 years and the group that recurred after 2 years.
In regard to the incidence of recurrence and the timing, there were 195 patients (77.69%) and 56 patients (22.31%) in each group, respectively, and the early recurrence group was larger. In the early recurrence group, the size of tumor was significantly larger (P=0.029).
In addition, serous infiltration (P=0.038), lymph node metastasis (P=0.001), and the incidence of vascular infiltration (P＜0.001) were significantly higher in the early recurrence group. They reported that the expression of c-erb B2 was significantly higher in the recurrence group (P=0.024).
In this current study, based on 72 patients (23.2%) whose recurrence time was within 1 year and 92 patients (29.6%) whose recurrence time was longer than 3 years, the patients who died of recurred gastric cancer after radical resection were divided to the early recurrence group, the mid recurrence group and the late recurrence group. Different from most studies(6,9,11-13) that classified patients based on 2 years after surgery.
In this study we defined the early recurrence group based on the approximately early 25% cases of all recurrence cases and the late recurrence group based on the approximately late 25% cases of all recurrence cases.
Thus, if recurrence could be detected early based on our study' s data, this could be an important for more aggressive therapies for recurrent lesions rather than just performing radical resection. In the early recurrence group, as compared with the late recurrence group, an advanced disease stage was more prevalent, the mean age was higher, the incidence of vascular, lymph duct and perineural infiltration was higher and the histological types with poor differentiation were more abundant. Particularly, for the patients with a highly advanced gastric cancer (stage III, stage IV), perineural infiltration was abundant in the early recurrence group, and there were significantly more cases with a relatively small number of dissected lymph nodes. In such a manner, although the recurrence time was different according to the disease stages, within a same disease stage, some clinicopathological factors showed significant differences according to the recurrence time.
Lymph node metastasis is a well known prognostic factor that exerts effects on the recurrence rate as well as the overall survival rate. Tumor cells released from primary lesions penetrate the basement membrane, they transverse the interstitial tissues and penetrate the vascular basement membrane, they enter the circulation system and then they form tumor cell embolism. They, in turn, are released again through the basement membrane and form distant metastatic lesions. In addition, it has been reported that perineural infiltration, which has already been recognized as a major factor that mediates effects on tumor recurrence after Table 6 . Post-operative surveillance schedule according to stage (Table 6 ). In such a manner, the followup observation is performed differently according to the disease stage in order to detect recurrence after surgery early and to facilitate establishing treatment plans accordingly.
It is clear that an early diagnosis and radical resection during the initial surgery are the most important factors to increase the survival rate and to lower the recurrence rate. It is also true that with the development of chemotherapy, immunotherapy and other diverse therapies, the survival rate and treatment outcomes are improving.(21-23) Nonetheless, gastric cancer recurs after surgery in many patients, and once cancer recurs, the prognosis is very poor because definite treatments have not been established.
(24-26) Gastric cancer is different from other cancers, it recurs as asynchronous multicentric cancer rather than locally, and so radical resection is difficult in many cases, and the cancer's responsiveness to systemic treatments such as chemotherapy is poor (25) (26) (27) Gastric cancer shows complex patterns of recurring at diverse times and the studies on factors that can predict the recurrence time are not still sufficient.
However, it has been reported that after radical resection, the survival rate can be increased through efforts to detect recurrence and it would be of great help to improve the prognosis through appropriate treatments at early times.
